on OXURION (EBR:OXUR)
Oxurion receives adjusted transparency notification
Leuven, Belgium – On March 27, 2025, Oxurion NV, a biopharmaceutical company listed on the Brussels Stock Exchange, announced that it had received an adjusted transparency notification from Atlas Special Opportunities II LLC. This information complies with the requirements of Belgian transparency legislation.
The notification, dated March 27, 2025, indicates that Atlas Special Opportunities II LLC held 134,344 shares as of March 17, out of an existing total of 3,638,344 shares. Through this transaction, Atlas fell below the 5% ownership threshold by selling voting shares.
This press release replaces the one published on March 18, 2025.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all OXURION news